Vanguard Group
GDRX icon

Vanguard Group’s GoodRx Holdings GDRX Stock Holding History

Vanguard Group’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$26M Buy
9,584,183
+376,843
+4% +$1.24M ﹤0.01% 2497
2025
Q3 		$38.9M Buy
9,207,340
+624,182
+7% +$2.74M ﹤0.01% 2275
2025
Q2 		$42.7M Sell
8,583,158
-41,714
-0.5% -$181K ﹤0.01% 2204
2025
Q1 		$38M Buy
8,624,872
+251,833
+3% +$1.18M ﹤0.01% 2214
2024
Q4 		$38.9M Buy
8,373,039
+460,753
+6% +$2.53M ﹤0.01% 2269
2024
Q3 		$54.9M Sell
7,912,286
-219,937
-3% -$1.73M ﹤0.01% 2135
2024
Q2 		$63.4M Buy
8,132,223
+31,157
+0.4% +$231K ﹤0.01% 2055
2024
Q1 		$57.5M Sell
8,101,066
-279,924
-3% -$1.85M ﹤0.01% 2107
2023
Q4 		$56.2M Sell
8,380,990
-300,121
-3% -$1.69M ﹤0.01% 2139
2023
Q3 		$48.9M Buy
8,681,111
+177,961
+2% +$1.19M ﹤0.01% 2147
2023
Q2 		$46.9M Buy
8,503,150
+128,410
+2% +$691K ﹤0.01% 2213
2023
Q1 		$52.3M Buy
8,374,740
+546,107
+7% +$3.04M ﹤0.01% 2161
2022
Q4 		$36.5M Sell
7,828,633
-1,708
-0% -$8.41K ﹤0.01% 2332
2022
Q3 		$36.6M Buy
7,830,341
+739,017
+10% +$4.66M ﹤0.01% 2331
2022
Q2 		$42M Buy
7,091,324
+1,178,059
+20% +$13.1M ﹤0.01% 2278
2022
Q1 		$114M Sell
5,913,265
-137,600
-2% -$3.16M ﹤0.01% 1865
2021
Q4 		$198M Buy
6,050,865
+526,719
+10% +$21.2M ﹤0.01% 1613
2021
Q3 		$227M Buy
5,524,146
+320,500
+6% +$11.6M 0.01% 1530
2021
Q2 		$187M Buy
5,203,646
+1,997,800
+62% +$73.7M ﹤0.01% 1664
2021
Q1 		$125M Sell
3,205,846
-241,020
-7% -$10.8M ﹤0.01% 1831
2020
Q4 		$139M Buy
3,446,866
+1,038,927
+43% +$47.7M ﹤0.01% 1664
2020
Q3 		$134M Buy
+2,407,939
New +$127M ﹤0.01% 1526

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
TCMX
Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

Vanguard Group's GDRX Position: Q4 2025 in Review

Vanguard Group increased its GoodRx Holdings (GDRX) stake by 4.1% in Q4 2025, buying an estimated $1.24M and bringing the position to 9,584,183 shares worth $26M. The position accounts for ﹤0.01% of the portfolio, ranked #2497.

Vanguard Group first reported a position in GDRX in Q3 2020 and has held it in 22 quarters since. The position peaked at $227M in Q3 2021. 183 funds tracked by Wall St. Rank hold GDRX as of Q4 2025.

  • Vanguard Group held 9,584,183 shares of GoodRx Holdings worth $26M as of Q4 2025.
  • Vanguard Group bought 376,843 GoodRx Holdings shares in Q4 2025, an estimated $1.24M.
  • GoodRx Holdings made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2497 holding.
  • Vanguard Group first reported a position in GoodRx Holdings in Q3 2020 and has held it in 22 quarters since.
  • Vanguard Group's GoodRx Holdings position peaked at $227M in Q3 2021.
  • 183 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.